1,050
Views
10
CrossRef citations to date
0
Altmetric
Theme: Inflammation and infection of the heart - Review

Cardiovascular magnetic resonance imaging of myocardial inflammation

&
Pages 1193-1201 | Published online: 10 Jan 2014

References

  • Hundley WG, Bluemke DA, Finn JP et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation121, 2462–2508 (2010).
  • Friedrich MG, Sechtem U, Schulz-Menger J et al. Cardiovascular magnetic resonance in myocarditis: a JACC White paper. J. Am. Coll. Cardiol.53, 1475–1487 (2009).
  • Friedrich MG. Myocardial edema – a new clinical entity? Nat. Rev. Cardiol.7, 292–296 (2010).
  • Edwards NC, Routledge H, Steeds RP. T2-weighted magnetic resonance imaging to assess myocardial oedema in ischaemic heart disease. Heart95, 1357–1361 (2009).
  • Abdel-Aty H, Simonetti O, Friedrich MG. T2-weighted cardiovascular magnetic resonance imaging. J. Magn. Reson. Imaging26, 452–459 (2007).
  • Aletras AH, Tilak GS, Natanzon A et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation113, 1865–1870 (2006).
  • Abdel-Aty H, Cocker M, Meek C, Tyberg JV, Friedrich MG. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J. Am. Coll. Cardiol.53, 1194–1201 (2009).
  • Desai KV, Laine GA, Stewart RH et al. Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am. J. Physiol. Heart Circ. Physiol.294, H2428–H2434 (2008).
  • Bijnens B, Sutherland GR. Myocardial oedema: a forgotten entity essential to the understanding of regional function after ischaemia or reperfusion injury. Heart94, 1117–1119 (2008).
  • Abdel-Aty H, Boye P, Zagrosek A et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J. Am. Coll. Cardiol.45, 1815–1822 (2005).
  • Eitel I, Desch S, Fuernau G et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J. Am. Coll. Cardiol.55, 2470–2479 (2010).
  • Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc. Imaging2, 825–831 (2009).
  • Cury RC, Shash K, Nagurney JT et al. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation118, 837–844 (2008).
  • Carlsson M, Ubachs JF, Hedstrom E, Heiberg E, Jovinge S, Arheden H. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc. Imaging2, 569–576 (2009).
  • Jeserich M, Olschewski M, Bley T et al. Cardiac involvement after respiratory tract viral infection – detection by cardiac magnetic resonance. J. Comput. Assist. Tomogr.33, 15–19 (2009).
  • Yelgec NS, Dymarkowski S, Ganame J, Bogaert J. Value of MRI in patients with a clinical suspicion of acute myocarditis. Eur. Radiol.17, 2211–2217 (2007).
  • Wince WB, Kim RJ. Molecular imaging: T2-weighted CMR of the area at risk – a risky business? Nat. Rev. Cardiol.7, 547–549 (2010).
  • Eitel I, Friedrich MG. T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J. Cardiovasc. Magn. Reson.13, 13 (2011).
  • Dwyer AJ, Frank JA, Sank VJ, Reinig JW, Hickey AM, Doppman JL. Short-Ti inversion-recovery pulse sequence: analysis and initial experience in cancer imaging. Radiology168, 827–836 (1988).
  • Francone M, Carbone I, Agati L et al. Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease. Radiol. Med.116, 32–46 (2011).
  • Zhou X, Rundell V, Liu Y et al. T(2)-weighted STIR imaging of myocardial edema associated with ischemia-reperfusion injury: the influence of proton density effect on image contrast. J. Magn. Reson. Imaging33, 962–967 (2011).
  • Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn. Reson. Med.57, 891–897 (2007).
  • Berry C, Kellman P, Mancini C et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ. Cardiovasc. Imaging3, 527–535 (2010).
  • Aletras AH, Kellman P, Derbyshire JA, Arai AE. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn. Reson. Med.59, 229–235 (2008).
  • Payne AR, Casey M, McClure J et al. Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage. Circ. Cardiovasc. Imaging4, 210–219 (2011).
  • Giri S, Chung YC, Merchant A et al. T2 quantification for improved detection of myocardial edema. J. Cardiovasc. Magn. Reson.11, 56 (2009).
  • Verhaert D, Thavendiranathan P, Giri S et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc. Imaging4, 269–278 (2011).
  • Wang Y, Alkasab TK, Narin O et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology260(1), 105–111 (2011).
  • Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation97, 1802–1809 (1998).
  • Gutberlet M, Spors B, Thoma T et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology246, 401–409 (2008).
  • Zagrosek A, Abdel-Aty H, Boye P et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc. Imaging2, 131–138 (2009).
  • Jerosch-Herold M, Sheridan DC, Kushner JD et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol.295, H1234–H1242 (2008).
  • Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J. Cardiovasc. Magn. Reson.5, 505–514 (2003).
  • Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol.57, 891–903 (2011).
  • Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur. Heart J.26, 1461–1474 (2005).
  • Bohl S, Wassmuth R, Abdel-Aty H et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int. J. Cardiovasc. Imaging24, 597–607 (2008).
  • Hunold P, Schlosser T, Vogt FM et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. Am. J. Roentgenol.184, 1420–1426 (2005).
  • Cooper LT Jr. Myocarditis. N. Engl. J. Med.360, 1526–1538 (2009).
  • Cooper LT, Baughman KL, Feldman AM et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation116, 2216–2233 (2007).
  • Assomull RG, Lyne JC, Keenan N et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur. Heart J.28, 1242–1249 (2007).
  • Eitel I, Behrendt F, Schindler K et al. Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. Eur. Heart J.29, 2651–2659 (2008).
  • Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S. Diagnostic value of CMR in patients with biomarker-positive acute chest pain and unobstructed coronary arteries. JACC Cardiovasc. Imaging3, 661–664 (2010).
  • Baccouche H, Mahrholdt H, Meinhardt G et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur. Heart J.30, 2869–2879 (2009).
  • Mahfoud F, Gartner B, Kindermann M et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur. Heart J.32, 897–903 (2011).
  • Stewart GC, Lopez-Molina J, Gottumukkala RV et al. Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ. Heart Fail.4, 71–78 (2011).
  • Zagrosek A, Wassmuth R, Abdel-Aty H, Rudolph A, Dietz R, Schulz-Menger J. Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis – a CMR study. J. Cardiovasc. Magn. Reson.10, 19 (2008).
  • Puntmann VO, Taylor PC, Barr A, Schnackenburg B, Jahnke C, Paetsch I. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study. Rheumatology49, 528–535 (2010).
  • Dall’armellina E, Karia N, Lindsay AC et al. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ. Cardiovasc. Imaging4, 228–236 (2011).
  • Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation109, 1250–1258 (2004).
  • Mahrholdt H, Wagner A, Deluigi CC et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation114, 1581–1590 (2006).
  • Rottgen R, Christiani R, Freyhardt P et al. Magnetic resonance imaging findings in acute myocarditis and correlation with immunohistological parameters. Eur. Radiol.21, 1259–1266 (2011).
  • Yilmaz A, Kindermann I, Kindermann M et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation122, 900–909 (2010).
  • Angelini A, Calzolari V, Calabrese F et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart84, 245–250 (2000).
  • Caforio AL, Calabrese F, Angelini A et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur. Heart J.28, 1326–1333 (2007).
  • Costantini M, Oreto G, Albanese A et al. Presumptive myocarditis with ST-elevation myocardial infarction presentation in young males as a new syndrome. Clinical significance and long term follow up. Cardiovasc. Ultrasound9, 1 (2011).
  • Cocker MS, Abdel-Aty H, Strohm O, Friedrich MG. Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study. Heart95, 1925–1930 (2009).
  • Monney PA, Sekhri N, Burchell T et al. Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart97(16), 1312–1318 (2010).
  • Leurent G, Langella B, Fougerou C et al. Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries. Arch. Cardiovasc. Dis.104, 161–170 (2011).
  • Eitel I, Behrendt F, Schindler K, Gutberlet M, Schuler G, Thiele H. Takotsubo cardiomyopathy or myocardial infarction? Answers from delayed enhancement magnetic resonance imaging. Int. J. Cardiol.135, e9–e12 (2009).
  • Escher F, Westermann D, Gaub R et al. Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart97, 709–714 (2011).
  • Yared K, Baggish AL, Picard MH, Hoffmann U, Hung J. Multimodality imaging of pericardial diseases. JACC Cardiovasc. Imaging3, 650–660 (2010).
  • Verhaert D, Gabriel RS, Johnston D, Lytle BW, Desai MY, Klein AL. The role of multimodality imaging in the management of pericardial disease. Circ. Cardiovasc. Imaging3, 333–343 (2010).
  • Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. J. Cardiovasc. Magn. Reson.11, 14 (2009).
  • Taylor AM, Dymarkowski S, Verbeken EK, Bogaert J. Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. Eur. Radiol.16, 569–574 (2006).
  • Kojima S, Yamada N, Goto Y. Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging. N. Engl. J. Med.341, 373–374 (1999).
  • Noth I, Strek ME, Leff AR. Churg–Strauss syndrome. Lancet361, 587–594 (2003).
  • Wassmuth R, Gobel U, Natusch A et al. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg–Strauss syndrome. J. Card. Fail.14, 856–860 (2008).
  • Chun W, Grist TM, Kamp TJ, Warner TF, Christian TF. Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac resonance imaging. Circulation110, e19 (2004).
  • Debl K, Djavidani B, Buchner S et al. Time course of eosinophilic myocarditis visualized by CMR. J. Cardiovasc. Magn. Reson.10, 21 (2008).
  • Kim JS, Judson MA, Donnino R et al. Cardiac sarcoidosis. Am. Heart J.157, 9–21 (2009).
  • Vignaux O, Dhote R, Duboc D et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest122, 1895–1901 (2002).
  • Shimada T, Shimada K, Sakane T et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium–DTPA-enhanced magnetic resonance imaging. Am. J. Med.110, 520–527 (2001).
  • Schulz-Menger J, Wassmuth R, Abdel-Aty H et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart92, 399–400 (2006).
  • Patel MR, Cawley PJ, Heitner JF et al. Detection of myocardial damage in patients with sarcoidosis. Circulation120, 1969–1977 (2009).
  • Cheong BY, Muthupillai R, Nemeth M et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis.26, 39–46 (2009).
  • Shirani J, Roberts WC. Subepicardial myocardial lesions. Am. Heart J.125, 1346–1352 (1993).
  • Bagwan IN, Hooper LV, Sheppard MN. Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies. Virchows Arch.458(6), 671–678 (2011).
  • Roman MJ, Salmon JE. Cardiovascular manifestations of rheumatologic diseases. Circulation116, 2346–2355 (2007).
  • O’Neill SG, Woldman S, Bailliard F et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann. Rheum. Dis.68, 1478–1481 (2009).
  • Ishimori ML, Martin R, Berman DS et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc. Imaging4, 27–33 (2011).
  • Singh JA, Woodard PK, Davila-Roman VG et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus14, 137–144 (2005).
  • Abdel-Aty H, Siegle N, Natusch A et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus17, 561–567 (2008).
  • Giles JT, Malayeri AA, Fernandes V et al. Left ventricular structure and function by cardiac magnetic resonance imaging in rheumatoid arthritis. Arthritis Rheum.62, 940–951 (2010).
  • Butler CR, Thompson R, Haykowsky M, Toma M, Paterson I. Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review. J. Cardiovasc. Magn. Reson.11, 7 (2009).
  • Marie PY, Angioi M, Carteaux JP et al. Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J. Am. Coll. Cardiol.37, 825–831 (2001).
  • Taylor AJ, Vaddadi G, Pfluger H et al. Diagnostic performance of multisequential cardiac magnetic resonance imaging in acute cardiac allograft rejection. Eur. J. Heart Fail.12, 45–51 (2010).
  • Usta E, Burgstahler C, Aebert H et al. The challenge to detect heart transplant rejection and transplant vasculopathy non-invasively – a pilot study. J. Cardiothorac. Surg.4, 43 (2009).
  • Korosoglou G, Osman NF, Dengler TJ et al. Strain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients. Am. J. Transplant.9, 2587–2596 (2009).
  • Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation118, 2754–2762 (2008).
  • Schneider B, Athanasiadis A, Schwab J et al. [Clinical spectrum of tako-tsubo cardiomyopathy in Germany: results of the tako-tsubo registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK)]. Dtsch Med. Wochenschr.135, 1908–1913 (2010).
  • Fernandez-Perez GC, Aguilar-Arjona JA, de la Fuente GT et al. Takotsubo cardiomyopathy: assessment with cardiac MRI. AJR Am. J. Roentgenol.195, W139–W145 (2010).
  • Eitel I, Lucke C, Grothoff M et al. Inflammation in takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging. Eur. Radiol.20, 422–431 (2010).
  • Joshi SB, Chao T, Herzka DA et al. Cardiovascular magnetic resonance T2 signal abnormalities in left ventricular ballooning syndrome. Int. J. Cardiovasc. Imaging26, 227–232 (2010).
  • Elliott P, Arbustini E. The role of endomyocardial biopsy in the management of cardiovascular disease: a commentary on joint AHA/ACC/ESC guidelines. Heart95, 759–760 (2009).
  • Korkusuz H, Esters P, Huebner F, Bug R, Ackermann H, Vogl TJ. Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model. J. Cardiovasc. Magn. Reson.12, 49 (2010).
  • Johnstone RI, Greenwood JP, Biglands JD, Plein S, Ridgway JP, Radjenovic A. Assessment of tissue edema in patients with acute myocardial infarction by computer-assisted quantification of triple inversion recovery prepared MRI of the myocardium. Magn. Reson. Med.66(2), 565–574 (2011).
  • Higgins CB, Herfkens R, Lipton MJ et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am. J. Cardiol.52, 184–188 (1983).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.